Health Canada
NOTICE
Health Canada implementation of International Council for Harmonisation Q12 Technical and regulatory considerations for pharmaceutical product lifecycle management and Q14 Analytical procedure development: Notice
Published: 1/12/2026Detected: 3/22/2026
Summary preview
Implements ICH Q12 (pharmaceutical product lifecycle management) and ICH Q14 (analytical procedure development) considerations in Canada, signaling that future regulatory expectations for lifecycle changes and…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountmanufacturing
quality
clinical
safety
labeling
#ICH Q12
#ICH Q14
#pharmaceutical product lifecycle management
#analytical procedure development
#CMC
Official Source Document Source Verified
Access the original document directly from HEALTH CANADA.
More from Health Canada
- Advisory Committee: Review of the Federal Approach to Pandemic Science Advice and Research Coordination11/16/2026
- Advisory Committee: National Pharmacare Committee of Experts11/16/2026
- Advisory Committee: Ministerial Advisory Council on Mental Health11/16/2026
- Advisory Committee: Expert Task Force on Substance Use11/16/2026
- Advisory Committee: Expert Panel on MAID and Mental Illness11/16/2026